Redeye: LIDDS - Interesting times ahead

LIDDS has some interesting expected news flow in the near-term. Clinical data from the Phase IIb Liproca Depot study will be closely monitored, as will progress on the collaboration front. Note that our coverage of LIDDS will be in English going forward.

Read more at: 

Start following companies at Redeye to recieve the latest research within Technology and Life Science

This is a press release from Redeye - Research Powered Investment Banking.